Topical Pain Relief

LETS GEL KIT Available to Prevent Pain When Suturing

By July 18, 2017

The new Convenience Pack includes SuturaGel Methylcellulose Base, which is designed to reduce the amount of medication run-off from the treatment area.

Topical Analgesics for Chronic Pain: An Evidenced-Based Review

By September 21, 2016

An overall lack of quality evidence exists for the use of topical analgesics and anesthetics (creams, gels and patches) as a therapeutic method for treating chronic pain, according to a new review published in the journal Dermatitis.

Kovanaze Nasal Spray Approved for Dental Anesthesia

August 10, 2016

St. Renatus announced that the Food and Drug Administration (FDA) has approved Kovanaze (tetracaine HCl and oxymetazoline HCl) Nasal Spray, the first dental anesthetic administered as a nasal spray.

Efficacy of Buprenorphine Patches in Diabetic Peripheral Neuropathic Pain

By June 21, 2016

Transdermal buprenorphine may be an effective therapy for diabetic peripheral neuropathic pain (DPNP), however it was associated with a high rate of adverse events, mostly nausea and/or vomiting.

FDA Accepts ZTlido NDA for Postherpetic Neuralgia

By September 16, 2015

The FDA has accepted for filing the New Drug Application for ZTlido (lidocaine patch 1.8%; Scilex) for the treatment of postherpetic neuralgia.

Zingo Demonstrates Efficacy for Pain Reduction in Pediatrics

By September 02, 2015

Marathon Pharmaceuticals announced positive results from the Phase 3 study of Zingo (lidocaine hydrochloride monohydrate) for the reduction of venous access pain in pediatric patients.

Mylan Launches Generic Lidoderm Patch

By August 10, 2015

Mylan announced the launch of Lidocaine Patch 5%, the generic version of Endo's Lidoderm.

Capsaicin May Be Effective for Non-Allergic Rhinitis, Study Finds

By July 23, 2015

Capsaicin may be a treatment option for patients with idiopathic non-allergic rhinitis, concluded study authors from the Cochrane Ears, Nose and Throat Group.

Do Lidocaine Patches Reduce Pain After Robotic Cardiac Valve Surgery?

July 23, 2015

Lidocaine 5 percent patches had no impact on measures of acute or persistent pain

Needle-Free Lidocaine Delivery System Launched

September 09, 2014

Marathon announced the launch of Zingo (lidocaine HCl monohydrate) powder intradermal injection system for the management of venous access pain.

Persistent Pain in Older Patients: Best Practices

August 27, 2014

Persistent pain in later life is prevalent, costly, and often disabling to patients.

Synera Patch Now Approved for Home Use

June 09, 2014

Galen US Incorporated announced that the FDA has approved Synera (lidocaine and tetracaine) topical patch to be used at home for the prevention of needle stick pain associated with superficial IVs and superficial dermatological procedures

Emergency Burn Gel to Return to Retail Shelves

April 14, 2014

Quest Products has announced that it will now distribute Alocane Emergency Burn Gel (Lidocaine HCl 4%), a topical gel for pain and itch relief.

IGI Labs Approved for Lidocaine HCl Topical Solution

March 12, 2014

IGI Laboratories announced it has received approval from the FDA for its Abbreviated New Drug Application (ANDA) for Lidocaine HCl USP 4% Topical Solution.

Acupuncture May Relieve Tonsillectomy Pain in Children

December 20, 2013

Preliminary evidence indicates that acupuncture may decrease perceived pain in children and adolescents following tonsillectomy.

Intranasal Oxytocin Application Enhances Placebo Effect

October 23, 2013

Pain ratings for the placebo site were significantly lower compared with the control site across both treatment groups, despite identical thermal stimulation.

Dual Epidural Analgesia Most Effective for Scoliosis Surgery

September 18, 2013

Dual continuous epidural analgesia (CEA) is the most effective pain control method following surgery for adolescent idiopathic scoliosis.

Actavis Launches Generic Lidoderm Patch

September 16, 2013

Actavis announced the launch of Lidocaine Topical Patch 5%, the generic version of Endo Pharmaceutical's Lidoderm.

Elorac's Topical Naloxone Lotion Granted Fast Track Designation

April 12, 2013

The FDA has granted Fast Track designation to Elorac's naloxone topical lotion, an opiate antagonist with no agonist activity, for the relief of pruritus in patients with cutaneous T-cell lymphoma.

Pliaglis Cream Now Available for Topical Local Analgesia

March 11, 2013

Topical anesthetic Pliaglis Cream is now available as a local analgesic for superficial dermatological procedures such as dermal filler injection and pulsed dye laser therapy.